BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27049262)

  • 1. Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
    Song W; Liu MG; Zhang JB; Zhang JJ; Sun MM; Yu QK
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1093-7. PubMed ID: 27049262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between EBV DNA and rearrangement and expression of Bcl-2 gene in aggressive non-Hodgkin's lymphoma.
    Eissa S; Kassim SK; Imam M; Khalifa A
    IUBMB Life; 1999 Aug; 48(2):231-6. PubMed ID: 10794603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.
    Carbone A; Gaidano G; Gloghini A; Pastore C; Saglio G; Tirelli U; Dalla-Favera R; Falini B
    Am J Pathol; 1997 Jan; 150(1):155-65. PubMed ID: 9006332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease.
    Kingma DW; Medeiros LJ; Barletta J; Raffeld M; Mann RB; Ambinder RF; Jaffe ES
    Am J Surg Pathol; 1994 Jan; 18(1):48-61. PubMed ID: 8279628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.
    Lima VP; de Lima MA; André AR; Ferreira MV; Barros MA; Rabenhorst SH
    World J Gastroenterol; 2008 Feb; 14(6):884-91. PubMed ID: 18240345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
    Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
    Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.
    Lan J; Xiong YY; Lin YX; Wang BC; Gong LL; Xu HS; Guo GS
    World J Gastroenterol; 2003 Jan; 9(1):54-8. PubMed ID: 12508351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma.
    Subar M; Neri A; Inghirami G; Knowles DM; Dalla-Favera R
    Blood; 1988 Aug; 72(2):667-71. PubMed ID: 2840989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.
    Inghirami G; Macri L; Cesarman E; Chadburn A; Zhong J; Knowles DM
    Blood; 1994 Jun; 83(12):3581-90. PubMed ID: 8204884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
    Williams ME; Frierson HF; Tabbarah S; Ennis PS
    Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
    Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
    Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
    Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus.
    Kanavaros P; Ioannidou D; Tzardi M; Datseris G; Katsantonis J; Delidis G; Tosca A
    Pathol Res Pract; 1994 Sep; 190(8):767-74. PubMed ID: 7831152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue markers of Epstein-Bar virus (EBV) infection in B-cell non-Hodgkin's lymphomas.
    Kasprzak A; Spachacz R; Hałoń A; Jeleń M; Stefańska K; Wachowiak J; Trejster E; Zabel M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):639-48. PubMed ID: 17317895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma.
    Wu H; Ma Y; Zhu Y; Shen Y; Gu C; Ye Z; Lin H
    Leuk Lymphoma; 2006 Jun; 47(6):1110-6. PubMed ID: 16840203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.